Aurobindo arm’s Biosimilar Gets Marketing Nod From U.K.’s MHRA
14 May 2025 //
THEHINDU
CuraTeQ Biologics gets positive opinion for Dazublys biosimilar
28 Apr 2025 //
INDPHARMAPOST
CuraTeQ Biologics finishes Phase 1 study of Denosumab biosimilar
09 Apr 2025 //
INDPHARMAPOST
CuraTeQ Biologics receives positive opinion for biosimilar Dyrupeg from EMA
03 Feb 2025 //
INDPHARMAPOST